from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/948742
via IFTTT
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/948701
via IFTTT
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/948516
via IFTTT
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/948678
via IFTTT
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/948677
via IFTTT
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/948675
via IFTTT
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/948518
via IFTTT
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/947068
via IFTTT
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/947809
via IFTTT
After chemo for recurrent ovarian cancer, oral maintenance therapy with an inhibitor of poly (ADP-ribose) polymerase (PARP) has shown benefits in women with platinum-sensitive ovarian cancer. According to a recent research review publication, the advantage of this special treatment was specifically obvious in patients with the BRCA mutation. BRCA anomalies can be considered either a […]
This post Ovarian cancer treatment with PARP inhibitors after recurrence first appeared on Gynecologic Oncology Institute | Robotic Surgery | Integrative Healing and is written by Dr Steve Vasilev MD
from Gynecologic Oncology Institute | Robotic Surgery | Integrative Healing https://www.gynecologiconcologyinstitute.org/news/ovarian-cancer/ovarian-cancer-treatment-with-parp-inhibitors-after-recurrence/
via Gynecologic Oncology Institute
from Gynecologic Oncology Institute https://gynecologiconcologyinstitute.tumblr.com/post/647486364901949440
via Frank Herd
Frank Herd 